Reintroduced the bipartisan Ensuring Timely Access to Generics Act, which she said would lower prescription drug costs by removing barriers that delay generic drugs from reaching the market and increasing competition.

Stated position. What this official has said they believe on this issue — a sourced claim, shown distinctly from any assessment of what they did. It is never scored and never affects the Integrity Score.

Derived from a tracked promise: “Reintroduced the bipartisan Ensuring Timely Access to Generics Act, which she said would lower prescription drug costs by removing barriers …”